Sol Net Income From Continuing Ops from 2010 to 2026

SLGL Stock  USD 64.22  3.37  5.54%   
Sol Gel Net Loss yearly trend continues to be quite stable with very little volatility. The value of Net Loss is projected to decrease to about -10 M. From the period between 2010 and 2026, Sol Gel, Net Loss regression line of its data series had standard deviation of  11,222,587 and standard deviation of  11,222,587. View All Fundamentals
 
Net Loss  
First Reported
2015-12-31
Previous Quarter
11.6 M
Current Value
-5.9 M
Quarterly Volatility
7.2 M
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Sol Gel financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sol Gel's main balance sheet or income statement drivers, such as Depreciation And Amortization of 254.6 K, Interest Expense of 1.6 M or Selling General Administrative of 6.8 M, as well as many indicators such as Price To Sales Ratio of 24.53, Dividend Yield of 0.0 or PTB Ratio of 8.49. Sol financial statements analysis is a perfect complement when working with Sol Gel Valuation or Volatility modules.
  
Build AI portfolio with Sol Stock
Check out the analysis of Sol Gel Correlation against competitors.
Historical Net Income From Continuing Ops data for Sol Gel serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Sol Gel Technologies represents a compelling investment opportunity.

Latest Sol Gel's Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of Sol Gel Technologies over the last few years. It is Sol Gel's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sol Gel's overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Pretty Stable
   Net Income From Continuing Ops   
       Timeline  

Sol Net Income From Continuing Ops Regression Statistics

Arithmetic Mean(14,254,712)
Geometric Mean11,039,637
Coefficient Of Variation(78.73)
Mean Deviation9,619,767
Median(9,998,100)
Standard Deviation11,222,587
Sample Variance125.9T
Range35.4M
R-Value(0.26)
Mean Square Error125.2T
R-Squared0.07
Significance0.31
Slope(580,250)
Total Sum of Squares2015.1T

Sol Net Income From Continuing Ops History

2026-10 M
2025-9.5 M
2024-10.6 M
2023-28.2 M
2022-14.9 M
20213.2 M
2020-29.3 M

About Sol Gel Financial Statements

Sol Gel investors utilize fundamental indicators, such as Net Income From Continuing Ops, to predict how Sol Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Loss-9.5 M-10 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Sol Gel Technologies is a strong investment it is important to analyze Sol Gel's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Sol Gel's future performance. For an informed investment choice regarding Sol Stock, refer to the following important reports:
Check out the analysis of Sol Gel Correlation against competitors.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sol Gel. If investors know Sol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Sol Gel assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth
4.876
Earnings Share
(1.22)
Revenue Per Share
8.59
Quarterly Revenue Growth
2.177
Return On Assets
(0.07)
Investors evaluate Sol Gel Technologies using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Sol Gel's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Sol Gel's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Sol Gel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sol Gel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Sol Gel's market price signifies the transaction level at which participants voluntarily complete trades.